+1 347 708 0418
This report studies the Tardive Dyskinesia (TD) Treatment market, covering market size for segment by type (Valbenazine, Amantadine, etc.), by application (Hospitals, Clinics, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Teva Pharma, Biogen, Johnson & Johnson, GlaxoSmithKline, Neurocrine Biosciences, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Tardive Dyskinesia (TD) Treatment from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Tardive Dyskinesia (TD) Treatment market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Tardive Dyskinesia (TD) Treatment including:
Teva Pharma
Biogen
Johnson & Johnson
GlaxoSmithKline
Neurocrine Biosciences
Pfizer
Novartis
Sanofi
AstraZeneca
Bayer AG
Bausch Health
Market split by Type, can be divided into:
Valbenazine
Amantadine
Tetrabenazine
Clonazepam
Market split by Application, can be divided into:
Hospitals
Clinics
Others
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 Tardive Dyskinesia (TD) Treatment Market Overview
1.1 Tardive Dyskinesia (TD) Treatment Definition
1.2 Global Tardive Dyskinesia (TD) Treatment Market Size Status and Outlook (2016-2030)
1.3 Global Tardive Dyskinesia (TD) Treatment Market Size Comparison by Region (2016-2030)
1.4 Global Tardive Dyskinesia (TD) Treatment Market Size Comparison by Type (2016-2030)
1.5 Global Tardive Dyskinesia (TD) Treatment Market Size Comparison by Application (2016-2030)
1.6 Global Tardive Dyskinesia (TD) Treatment Market Size Comparison by Sales Channel (2016-2030)
1.7 Tardive Dyskinesia (TD) Treatment Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Tardive Dyskinesia (TD) Treatment Market Segment Analysis by Player
2.1 Global Tardive Dyskinesia (TD) Treatment Sales and Market Share by Player (2019-2021)
2.2 Global Tardive Dyskinesia (TD) Treatment Revenue and Market Share by Player (2019-2021)
2.3 Global Tardive Dyskinesia (TD) Treatment Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Tardive Dyskinesia (TD) Treatment Market Segment Analysis by Type
3.1 Global Tardive Dyskinesia (TD) Treatment Market by Type
3.1.1 Valbenazine
3.1.2 Amantadine
3.1.3 Tetrabenazine
3.1.4 Clonazepam
3.2 Global Tardive Dyskinesia (TD) Treatment Sales and Market Share by Type (2016-2021)
3.3 Global Tardive Dyskinesia (TD) Treatment Revenue and Market Share by Type (2016-2021)
3.4 Global Tardive Dyskinesia (TD) Treatment Average Price by Type (2016-2021)
3.5 Leading Players of Tardive Dyskinesia (TD) Treatment by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Tardive Dyskinesia (TD) Treatment Market Segment Analysis by Application
4.1 Global Tardive Dyskinesia (TD) Treatment Market by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Tardive Dyskinesia (TD) Treatment Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Tardive Dyskinesia (TD) Treatment by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Tardive Dyskinesia (TD) Treatment Market Segment Analysis by Sales Channel
5.1 Global Tardive Dyskinesia (TD) Treatment Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Tardive Dyskinesia (TD) Treatment Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Tardive Dyskinesia (TD) Treatment by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Tardive Dyskinesia (TD) Treatment Market Segment Analysis by Region
6.1 Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR by Region (2016-2030)
6.2 Global Tardive Dyskinesia (TD) Treatment Sales and Market Share by Region (2016-2021)
6.3 Global Tardive Dyskinesia (TD) Treatment Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Tardive Dyskinesia (TD) Treatment Market Share by Type
6.4.3 North America Tardive Dyskinesia (TD) Treatment Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Tardive Dyskinesia (TD) Treatment Market Share by Type
6.5.3 Europe Tardive Dyskinesia (TD) Treatment Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Type
6.6.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Tardive Dyskinesia (TD) Treatment Market Share by Type
6.7.3 South America Tardive Dyskinesia (TD) Treatment Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Type
6.8.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Tardive Dyskinesia (TD) Treatment Players
7.1 Teva Pharma
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Biogen
7.3 Johnson & Johnson
7.4 GlaxoSmithKline
7.5 Neurocrine Biosciences
7.6 Pfizer
7.7 Novartis
7.8 Sanofi
7.9 AstraZeneca
7.10 Bayer AG
7.11 Bausch Health
Chapter 8 Upstream and Downstream Analysis of Tardive Dyskinesia (TD) Treatment
8.1 Industrial Chain of Tardive Dyskinesia (TD) Treatment
8.2 Upstream of Tardive Dyskinesia (TD) Treatment
8.3 Downstream of Tardive Dyskinesia (TD) Treatment
Chapter 9 Development Trend of Tardive Dyskinesia (TD) Treatment (2022-2030)
9.1 Global Tardive Dyskinesia (TD) Treatment Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Tardive Dyskinesia (TD) Treatment Example
Figure Global Tardive Dyskinesia (TD) Treatment Revenue (Million $) Status and Outlook (2016-2030)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue (Million $) Comparison by Region (2016-2030)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue (Million $) Comparison by Type (2016-2030)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue (Million $) Comparison by Application (2016-2030)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global Tardive Dyskinesia (TD) Treatment Sales by Player (2019-2021)
Table Global Tardive Dyskinesia (TD) Treatment Sales Market Share by Player (2019-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Sales Market Share by Player in 2021
Table Global Tardive Dyskinesia (TD) Treatment Revenue (Million $) by Player (2019-2021)
Table Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Player (2019-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Player in 2021
Table Global Tardive Dyskinesia (TD) Treatment Average Price by Player (2019-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Average Price by Player in 2021
Figure Global Tardive Dyskinesia (TD) Treatment Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global Tardive Dyskinesia (TD) Treatment Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of Valbenazine
Figure Global Valbenazine Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Amantadine
Figure Global Amantadine Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Tetrabenazine
Figure Global Tetrabenazine Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Clonazepam
Figure Global Clonazepam Revenue (Million $) and Growth Rate (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Sales by Type (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Sales Market Share by Type (2016-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Sales Market Share by Type in 2021
Table Global Tardive Dyskinesia (TD) Treatment Revenue (Million $) by Type (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2016-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type in 2021
Table Global Tardive Dyskinesia (TD) Treatment Average Price by Type (2016-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Average Price by Type in 2021
Table Leading Players of Tardive Dyskinesia (TD) Treatment by Type in 2021
Figure Example of Hospitals
Figure Global Tardive Dyskinesia (TD) Treatment for Hospitals Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Clinics
Figure Global Tardive Dyskinesia (TD) Treatment for Clinics Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global Tardive Dyskinesia (TD) Treatment for Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Sales by Application (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Sales Market Share by Application (2016-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Sales Market Share by Application in 2021
Table Leading Consumers of Tardive Dyskinesia (TD) Treatment by Application in 2021
Figure Example of Direct Channel
Figure Global Tardive Dyskinesia (TD) Treatment for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global Tardive Dyskinesia (TD) Treatment for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Revenue by Sales Channel (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Sales Channel (2016-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of Tardive Dyskinesia (TD) Treatment by Sales Channel in 2021
Table Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR by Region (2016-2030)
Table Global Tardive Dyskinesia (TD) Treatment Sales by Region (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Sales Market Share by Region (2016-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Sales Market Share by Region in 2021
Table Global Tardive Dyskinesia (TD) Treatment Revenue (Million $) by Region (2016-2021)
Table Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Region (2016-2021)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Region in 2021
Table North America Tardive Dyskinesia (TD) Treatment Sales by Country (2016-2021)
Figure North America Tardive Dyskinesia (TD) Treatment Sales Market Share by Country (2016-2021)
Table North America Tardive Dyskinesia (TD) Treatment Revenue by Country (2016-2021)
Figure North America Tardive Dyskinesia (TD) Treatment Revenue Market Share by Country (2016-2021)
Figure North America Tardive Dyskinesia (TD) Treatment Market Share by Type in 2021
Figure North America Tardive Dyskinesia (TD) Treatment Market Share by Application in 2021
Figure United States Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure United States Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Canada Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Mexico Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Table Europe Tardive Dyskinesia (TD) Treatment Sales by Country (2016-2021)
Figure Europe Tardive Dyskinesia (TD) Treatment Sales Market Share by Country (2016-2021)
Table Europe Tardive Dyskinesia (TD) Treatment Revenue by Country (2016-2021)
Figure Europe Tardive Dyskinesia (TD) Treatment Revenue Market Share by Country (2016-2021)
Figure Europe Tardive Dyskinesia (TD) Treatment Market Share by Type in 2021
Figure Europe Tardive Dyskinesia (TD) Treatment Market Share by Application in 2021
Figure Germany Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Germany Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure UK Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure UK Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure France Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure France Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Italy Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Russia Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Spain Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific Tardive Dyskinesia (TD) Treatment Sales by Country (2016-2021)
Figure Asia-Pacific Tardive Dyskinesia (TD) Treatment Sales Market Share by Country (2016-2021)
Table Asia-Pacific Tardive Dyskinesia (TD) Treatment Revenue by Country (2016-2021)
Figure Asia-Pacific Tardive Dyskinesia (TD) Treatment Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Type in 2021
Figure Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Application in 2021
Figure China Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure China Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Japan Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Korea Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure India Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure India Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Southeast Asia Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Australia Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Table South America Tardive Dyskinesia (TD) Treatment Sales by Country (2016-2021)
Figure South America Tardive Dyskinesia (TD) Treatment Sales Market Share by Country (2016-2021)
Table South America Tardive Dyskinesia (TD) Treatment Revenue by Country (2016-2021)
Figure South America Tardive Dyskinesia (TD) Treatment Revenue Market Share by Country (2016-2021)
Figure South America Tardive Dyskinesia (TD) Treatment Market Share by Type in 2021
Figure South America Tardive Dyskinesia (TD) Treatment Market Share by Application in 2021
Figure Brazil Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Brazil Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Argentina Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Colombia Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa Tardive Dyskinesia (TD) Treatment Sales by Country (2016-2021)
Figure Middle East & Africa Tardive Dyskinesia (TD) Treatment Sales Market Share by Country (2016-2021)
Table Middle East & Africa Tardive Dyskinesia (TD) Treatment Revenue by Country (2016-2021)
Figure Middle East & Africa Tardive Dyskinesia (TD) Treatment Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Type in 2021
Figure Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Application in 2021
Figure UAE Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure UAE Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure Saudi Arabia Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa Tardive Dyskinesia (TD) Treatment Sales and Growth Rate (2016-2021)
Figure South Africa Tardive Dyskinesia (TD) Treatment Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of Teva Pharma
Table Tardive Dyskinesia (TD) Treatment Introduction of Teva Pharma
Table Tardive Dyskinesia (TD) Treatment Sales, Price, Revenue, Gross Margin and Market Share of Teva Pharma (2019-2021)
Table Industrial Chain of Tardive Dyskinesia (TD) Treatment
Table Manufacturing Cost Structure of Tardive Dyskinesia (TD) Treatment
Table General Manufacturing Process of Tardive Dyskinesia (TD) Treatment
Table Leading Distributors/Dealers of Tardive Dyskinesia (TD) Treatment
Table Leading Consumers of Tardive Dyskinesia (TD) Treatment
Figure Global Tardive Dyskinesia (TD) Treatment Sales and Growth Rate Forecast (2022-2030)
Figure Global Tardive Dyskinesia (TD) Treatment Revenue and Growth Rate Forecast (2022-2030)
Table Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR Forecast by Region (2022-2030)
Table Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR Forecast by Type (2022-2030)
Table Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR Forecast by Application (2022-2030)
Table Global Tardive Dyskinesia (TD) Treatment Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
